Pınar TAMER, Burçin DURMUŞ, Muhteşem GEDİZLİOĞLU

EKSTAZİ İLE İLİŞKİLİ BİLATERAL BAZAL GANGLİON HEMORAJİSİ

Giriş: Bir amfetamin türevi olan MDMA (3-4 metilendioksimetamfetamin, “Ekstazi”) yaygın olarak kullanılan halusinojenik ve stimulan özellikte bir bileşimdir. Diğer sempatomimetik ilaçlara benzer şekilde, kullanımı ciddi sistemik ve nörolojik komplikasyonlarla ilişkilendirilmiştir. Olgu: Bu çalışmada bilinç bozukluğu nedeniyle acile getirilen, bilateral bazal gangliyon düzeyinde hemoraji saptanması üzerine kliniğimizde izlenen 35 yaşında kadın hasta sunuldu. Ekstazi kullanımından 10 saat sonra semptomları başlayan hasta medikal tedavi ile takip edildi. Sonuç: Sıklıkla hasta ve yakınları tarafından madde kullanım öyküsü gizlenebilmektedir. Olgumuz atipikin trakranial hemoraji saptanan hastalarda madde kullanımının mutlaka sorgulanması gerektiğini vurgulamak için sunulmaya değer bulunmuştur.

BILATERAL BASAL GANGLIA HEMORRHAGE RELATED WITH ECSTASY

Introduction: An amphetamine derivative MDMA (3-4 methylenedioxymethamphetamine, " Ecstasy") is a commonly used hallucinogenic and stimulant compound. Similar toother sympathomimetic drugs, it suse has been associated with severe systemic and neurological complications. Case: In this study, we present a 35-year-old female patient who was diagnosed as having bilateral basal ganglion hemorrhage due to unconsciousness and followed up in our clinic. The patient, whose symptoms started 10 hours after the use of Extasy, was followed up with medical treatment. Conclusion: Often, the narrative of substance use can be hidden by patients and their relatives. We have been presented to emphasize that substance use in patients with atypical intracranial hemorrhage should be questioned.

PDF

___

1. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylene dioxymethamphetamine (‘Ecstasy’). Lancet 1992; 340(8816): 384–7.
2. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.CMAJ. 2001; 165(7): 917-28.
3. Rosenson J, Smollin C, Sporer KA, Blanc P, Olson KR. Patterns of ecstasy-associated hyponatremia in California. Ann Emerg Med 2007; 49(2):164-71.
4. Duflou J, Mark A. Aortic dissection after ingestion of "ecstasy" (MDMA).Am J Forensic Med Pathol 2000; 21(3): 261-3.
5. Kahn DE, Ferraro N, Benveniste RJ. 3 cases of primary intracranial hemorrhage associated with ‘Molly’, a purified form of 3,4-methylenedioxymethamphetamine (MDMA). J Neurol Sci 2012; 323(1-2): 257–60.
6. Selmi F, Davies KG, Sharma RR, Neal JW. Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations. Br J Neurosurg 1995; 9(1): 93–6.
7. Baylen CA, Rosenberg H. A review of the acute subjective effects of MDMA / ecstasy. Addiction 2006; 101(7): 933-47.
8. Kim HJ, Na JY, Lee YJ, Park JT, Kim HS. An autopsy case of methanol induced intracranial hemorrhage. Int J Clin Exp Pathol 2015; 8(10): 13643-6.
9. Stemer A, Ouyang B, Lee VH, Prabhakaran S: Prevalence and risk factors for multiple simultaneous intracerebral hemorrhages. Cerebrovasc Dis 2010; 30: 302–7.
10. Laiwattana D, Sangsawang B, Sangsawang N.Primary Multiple simultaneous ıntracerebral hemorrhages betweeen1950 and 2013: analysis of data on age, sex and outcome.Cerebrovasc Dis Extra. 2014; 4(2): 102-14.
11. Yen CP, Lin CL, Kwan AL, Lieu AS, Hwang SL, Lin CN, et al. Simultaneous multiple hypertensive intracerebral hemorrhages. Acta Neurochir (Wien) 2005;147:393–9.
12. Permpalung N, Cheungpasitporn W, Chongnarungsin D, Hodgdon TM. Bilateral putaminal hemorrhages: serious complication of methanolin toxication. N Am J Med Sci 2013; 5(10): 623-4.